Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,100 | 81,800 | 95,700 | 127,700 | 117,000 |
| Receivables | 145,200 | 152,300 | 142,700 | 167,900 | 146,200 |
| Inventories | 156,600 | 148,300 | 200,000 | 132,300 | 193,600 |
| Other current assets | 102,100 | 108,700 | 0 | 182,300 | 0 |
| TOTAL | $524,600 | $506,900 | $453,800 | $624,100 | $470,000 |
| Non-Current Assets | |||||
| PPE Net | 116,800 | 122,600 | 163,500 | 118,600 | 163,400 |
| Intangibles | 1,033,700 | 985,200 | 1,066,200 | 994,500 | 1,082,300 |
| Other Non-Current Assets | 49,800 | 52,000 | 51,400 | 49,700 | 59,500 |
| TOTAL | $1,200,300 | $1,159,800 | $1,281,100 | $1,162,800 | $1,305,200 |
| Total Assets | $1,724,900 | $1,666,700 | $1,734,900 | $1,786,900 | $1,775,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 |
| Accounts payable and accrued liabilities | 52,100 | 65,400 | 59,600 | 67,900 | 62,700 |
| Accrued Expenses | 97,200 | 72,700 | 80,600 | 97,800 | 80,000 |
| Other current liabilities | 2,500 | 2,700 | N/A | 7,100 | N/A |
| TOTAL | $170,700 | $160,500 | $158,500 | $191,000 | $162,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 258,300 | 203,300 | 204,700 | 226,300 | 247,800 |
| Other Non-Current Liabilities | 45,100 | 46,300 | 47,900 | 53,000 | 64,600 |
| TOTAL | $332,100 | $271,400 | $277,700 | $304,700 | $349,400 |
| Total Liabilities | $502,800 | $431,900 | $436,200 | $495,700 | $511,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,426 | 46,873 | 46,667 | 46,599 | 46,498 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -325,400 | -321,700 | -253,600 | -253,100 | -270,000 |
| Other shareholders' equity | -32,700 | -27,900 | -31,200 | -35,600 | -43,300 |
| TOTAL | $1,222,100 | $1,234,800 | $1,298,700 | $1,291,200 | $1,263,500 |
| Total Liabilities And Equity | $1,724,900 | $1,666,700 | $1,734,900 | $1,786,900 | $1,775,200 |